CLPT Stock Summary and Trading Ideas (Clearpoint Neuro | NASDAQ:CLPT)

ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.

Clearpoint Neuro trades on the NASDAQ stock market under the symbol CLPT.

As of September 10, 2026, CLPT stock price declined to $13.34 with 211,993 million shares trading.

CLPT has a beta of 2.41, meaning it tends to be more sensitive to market movements. CLPT has a correlation of 0.08 to the broad based SPY ETF.

CLPT has a market cap of $400.06 million. This is considered a Small Cap stock.

Last quarter Clearpoint Neuro reported $11 million in Revenue and -$.38 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.10.

In the last 3 years, CLPT traded as high as $30.10 and as low as $4.05.

The top ETF exchange traded funds that CLPT belongs to (by Net Assets): VTI, VXF, IWO, VTWO, KOMP.

CLPT has outperformed the market in the last year with a return of +21.8%, while the SPY ETF gained +17.7%. However, in the most recent history, CLPT shares have underperformed the stock market with its stock returning -1.8% in the last 3 month period and -18.5% for the last 2 week period, while SPY has returned +3.1% and -1.1%, respectively.

CLPT support price is $13.36 and resistance is $14.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLPT shares will trade within this expected range on the day.